-Reuters
Biofrontera Inc. Announces Preliminary Q3 Revenues Of ~$8.7M-$9M Vs $7.03M Est.; Affirms Guidance For Full-Year Revenue Growth Of At Least 25% Over 2022
Revenues Increased 101% to 108% Over the Prior-Year QuarterAffirms Guidance for Full-Year Revenue Growth of at Least 25% over 2022WOBURN, MA / ACCESSWIRE / October 4, 2023 / Biofrontera Inc. (NASDAQ:BFRI) ("Biofrontera"